Skip to content

Acute exacerbation of fibrosing interstitial lung disease; multicenter retrospective cohort study

Acute exacerbation of fibrosing interstitial lung disease; multicenter retrospective cohort study - Cohort study of acute exacerbation of fibrosing interstitial lung disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043025
Enrollment
400
Registered
2021-01-16
Start date
2020-07-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute exacerbation of fibrosing interstitial lung disease

Interventions

None listed

Sponsors

Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cases treated for acute exacerbation of fibrosing interstitial lung disease between January 2012 and December 2019.

Exclusion criteria

Exclusion criteria: Cases in which the subject himself/herself has requested the refusal of the provision of information

Design outcomes

Primary

MeasureTime frame
To clarify the clinical course of fibrosing interstitial lung disease.

Countries

Japan

Contacts

Public ContactKatsuyuki Furuta

Wakayama Medical University Department of Pulmonary Medicine and Medical Oncology

k-furuta@wakayama-med.ac.jp073-441-0619

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026